Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Felix

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Brain Research|September 4, 2015
Cerebral glucose metabolism in adults with neurofibromatosis type 1Ivayla Apostolova, Thorsten Derlin, Johannes Salamon, et al.
Human Mutation|November 5, 2013
Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombinationKathrin Bengesser, Julia Vogt, Tanja Mussotter, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 10, 2020
Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndromeHagit Toledano-Alhadef, Victor-Felix Mautner, Isabel Gugel, et al.
Orphanet Journal of Rare Diseases|January 15, 2021
Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT)Maxim Avanesov, Lennart Well, Azien Laqmani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 16, 2020
Presenting symptoms in children with neurofibromatosis type 2Isabel Gugel, Florian Grimm, Christian Teuber, et al.
Cancers|November 27, 2019
Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 PatientsIsabel Gugel, Lan Kluwe, Julian Zipfel, et al.
Neuro-Oncology|February 13, 2010
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2Victor-Felix Mautner, Rosa Nguyen, Hannes Kutta, et al.
Computers in Biology and Medicine|December 28, 2025
MOIS-SAM2: Exemplar-based segment anything model 2 for multi-lesion interactive segmentation of neurofibromas in whole-body MRIGeorgii Kolokolnikov, Marie-Lena Schmalhofer, Sophie Götz, et al.
International Journal of Molecular Sciences|February 28, 2020
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In VivoAlexander Schulte, Florian Ewald, Melanie Spyra, et al.
Orphanet Journal of Rare Diseases|November 3, 2021
Alterations in brain morphology by MRI in adults with neurofibromatosis 1Su Wang, Victor-Felix Mautner, Ralph Buchert, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Brain Research|September 4, 2015
Cerebral glucose metabolism in adults with neurofibromatosis type 1Ivayla Apostolova, Thorsten Derlin, Johannes Salamon, et al.
Human Mutation|November 5, 2013
Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombinationKathrin Bengesser, Julia Vogt, Tanja Mussotter, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 10, 2020
Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndromeHagit Toledano-Alhadef, Victor-Felix Mautner, Isabel Gugel, et al.
Orphanet Journal of Rare Diseases|January 15, 2021
Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT)Maxim Avanesov, Lennart Well, Azien Laqmani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 16, 2020
Presenting symptoms in children with neurofibromatosis type 2Isabel Gugel, Florian Grimm, Christian Teuber, et al.
Cancers|November 27, 2019
Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 PatientsIsabel Gugel, Lan Kluwe, Julian Zipfel, et al.
Neuro-Oncology|February 13, 2010
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2Victor-Felix Mautner, Rosa Nguyen, Hannes Kutta, et al.
Computers in Biology and Medicine|December 28, 2025
MOIS-SAM2: Exemplar-based segment anything model 2 for multi-lesion interactive segmentation of neurofibromas in whole-body MRIGeorgii Kolokolnikov, Marie-Lena Schmalhofer, Sophie Götz, et al.
International Journal of Molecular Sciences|February 28, 2020
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In VivoAlexander Schulte, Florian Ewald, Melanie Spyra, et al.
Orphanet Journal of Rare Diseases|November 3, 2021
Alterations in brain morphology by MRI in adults with neurofibromatosis 1Su Wang, Victor-Felix Mautner, Ralph Buchert, et al.
Pageof 15